NL-OMON41760
Completed
N/A
European genetics study of hearing impairment in patients with cancer during childhood treated with cisplatin. - Genetic variation in ototoxicity after cisplatin treatment in children.
Overview
- Phase
- N/A
- Intervention
- Not specified
- Conditions
- hearing impairment
- Sponsor
- Erasmus MC, Universitair Medisch Centrum Rotterdam
- Enrollment
- 100
- Status
- Completed
- Last Updated
- 2 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- •Treated with cisplatin
- •Diagnosed before the age of 18 years
- •End\-of treatment pure tone audiograms
- •No radiotherapy administered to head/neck
- •Normal pre\-treatment audiogram
Exclusion Criteria
- •No informed consent
- •Pre\-existing known hearing impairment
Outcomes
Primary Outcomes
Not specified
Similar Trials
Recruiting
N/A
Hereditary hearing impairment in the Netherlands: elucidation of genetic causes, and clinical characterization.hereditary deafnesshereditary hearing impairment10013995NL-OMON47077KNO2,050
Terminated
N/A
Genetic Analysis of Human Hereditary Hearing ImpairmentPartial Hearing LossNCT00001606National Institute on Deafness and Other Communication Disorders (NIDCD)404
Not Yet Recruiting
N/A
Study of hearing lossCTRI/2017/04/008414Dr Saadi Abdul Vahab700
Completed
N/A
A prospective study of the hearing disorder in the patient receiving cisplatiMalignant tumorJPRN-UMIN000017989Kobe minimally invasive cancer center100
Completed
N/A
Investigation on Hearing and Dementia in selected Nursing Homes in and around Hanover / Lower Saxony.hearing loss, dementiaDRKS00026809KRH Nordstadt Krankenhaus Abteilung für HNO-Heilkunde107